Piramal Enterprises is currently trading at Rs. 1007.00, up by 20.60 points or 2.09% from its previous closing of Rs. 986.40 on the BSE.
The scrip opened at Rs. 990.00 and has touched a high and low of Rs. 1011.05 and Rs. 990.00 respectively. So far 2,011 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1043.00 on 20-May-2015 and a 52 week low of Rs. 805.00 on 18-Sep-2015.
Last one week high and low of the scrip stood at Rs. 1030.00 and Rs. 980.05 respectively. The current market cap of the company is Rs. 17,377.00 crore.
The promoters holding in the company stood at 52.82% while Institutions and Non-Institutions held 30.91% and 16.27% respectively.
Piramal Enterprises has received an approval for issue of secured Non-Convertible Debentures (NCDs) amounting up to Rs 500 crore. The meeting of Committee of Directors (Funding) held on January 05, 2016 has approved for the same.
Piramal Enterprises is one of the leading players globally in CRAMS (custom research and manufacturing services) as well as in the critical care segment of inhalation and injectable anaesthetics. It also has a strong presence in the OTC segment in India.
